Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Neuromed is a privately held biopharmaceutical company developing the next generation of chronic pain drugs with pipeline programs in anxiety, epilepsy and cardiovascular disease such as hypertension. Located in Vancouver, Canada and Conshohocken, USA, the Company’s drug development programs are designed around validated clinical targets associated with large unmet markets. Neuromed exclusively focuses on calcium channels as drug targets and is the first company to take an orally available drug selectively targeting neuronal calcium channels into human clinical trials. Neuromed is a spin-off biotechnology company from the University of British Columbia founded by Dr. Terrance Snutch, who is also a professor in the Michael Smith Laboratories at UBC. ( www.neuromed.com )
Neuromed Technologies Inc.
301 – 2389 Health Sciences Mall
Vancouver, British Columbia V6T 1Z4
Canada
Tel: (604) 909-2530
Fax: (604) 909-2538